Literature DB >> 19103574

Synthesis and evaluation of 2-substituted-6-phenyl-4,5-dihydropyridazin-3(2H)-ones as potent inodilators.

Dinesh Kumar1, Rosalia Carron, Carmen De La Calle, Dharam Paul Jindal, Ranju Bansal.   

Abstract

The present study describes the synthesis and pharmacological evaluation of 2-substituted-6-(4-acylaminophenyl)-4,5-dihydropyridazin-3(2H)-ones as potent inodilating agents. The synthesis of target compounds 2-4 and 7-11 was achieved by Friedel-Crafts acylation of appropriate anilide derivative with succinic anhydride or methylsuccinic anhydride and subsequent cyclization of intermediary keto acids with various hydrazine derivatives. The newly synthesized pyridazinone derivatives were evaluated for cardiotonic activity using isolated rat atria and for vasorelaxant activity using descending thoracic aortic rings of Wistar rats precontracted with phenylephrine (10-6 mol L-1). 6-(4-Methanesulfonamidophenyl)-2-phenyl-4,5-dihydropyridazin-3(2H)-one (7) exhibited significant inodilatory properties and showed vasorelaxant activity in a nanomolar range (IC50 = 0.08 +/- 0.01 mumol L-1).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19103574     DOI: 10.2478/v1007-008-0021-4

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  2 in total

1.  Synthesis of Some New Pyridazine Derivatives for Anti-HAV Evaluation.

Authors:  Eman M Flefel; Waled A Tantawy; Walaa I El-Sofany; Mahmoud El-Shahat; Ahmed A El-Sayed; Dina N Abd-Elshafy
Journal:  Molecules       Date:  2017-01-17       Impact factor: 4.411

2.  Phosphodiesterase-III Inhibitors Amrinone and Milrinone on Epilepsy and Cardiovascular Activities.

Authors:  Mohammad Asif
Journal:  N Am J Med Sci       Date:  2012-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.